United Therapeutics | UTHR - Прибыль до налогообложения





Прибыль до налогообложения Изменить Дата
Amarin USD -852K 7.26M 2025-12
Ardelyx USD -400K 467K 2025-12
Baxter International USD -756M 877M 2025-12
Bayer EUR -3.37B 2.21B 2025-12
BioCryst Pharmaceuticals USD 248.02M 235.89M 2025-12
Biogen USD 377.7M 433.7M 2026-03
BioMarin Pharmaceutical USD 141.2M 168.36M 2026-03
Esperion Therapeutics USD 63.67M 95M 2025-12
Gilead Sciences USD 2.08B 1.56B 2025-12
GlaxoSmithKline GBP 2.14B 919M 2026-03
Halozyme Therapeutics USD 180.33M 281.18M 2026-03
Insmed USD -162.1M 164.84M 2026-03
Ionis Pharmaceuticals USD -93M 135M 2026-03
J&J USD 7.82B 2.86B 2026-03
Lexicon Pharmaceuticals USD -12.77M 16.02M 2025-09
Moderna USD -799M 612M 2025-12
Omeros USD -65.12M 21.27M 2024-06
Pfizer USD 5.18B 6.82B 2026-03
PTC Therapeutics USD -2.46M 136.62M 2026-03
Regeneron Pharmaceuticals USD 1.04B 719.6M 2025-12
Sangamo BioSciences USD -36.05M 12.94M 2024-06
Sarepta Therapeutics USD 343.17M 750.85M 2026-03
Teva Pharmaceutical Industries USD 753M 662M 2026-03
United Therapeutics USD 444M 6M 2025-12
Vertex Pharmaceuticals USD 1.25B 78.1M 2026-03